http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 27 Aug 2026 12:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html <p class="bwalignc"> <b>(Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)</b> </p> <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics: (Paris:ABLD) </p><table cellspacing="0" class="bwtablemarginb bwblockalignl bwwidth100"> <tr> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Date</b> </p> </td> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Total Number of Shares Constituting the Share Capital</b> </p> </td> <td colspan="2" class="bwrowaltcolor0 bwpadl0 bwtopsingle bwleftsingle bwrightsingle" rowspan="1"><p class="bwalignc bwcellpmargin"> <b>Number of Voting Rights (1) (2)</b> </p> </td> </tr> <tr> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Theoretical Voting Rights</i></b> </p> </td> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwrightsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Exercisable Voting Rights</i></b> </p> </td> </tr> <tr> <td class="bwsinglebottom bwleftsingle http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html Thu, 27 Aug 2026 12:00:00 -0400 A.40419557 ABLD O.00384728 O.00384891 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html <p class="bwalignc"> <b>(Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)</b> </p> <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics: (Paris:ABLD) </p><table cellspacing="0" class="bwtablemarginb bwblockalignl bwwidth100"> <tr> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Date</b> </p> </td> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Total Number of Shares Constituting the Share Capital</b> </p> </td> <td colspan="2" class="bwrowaltcolor0 bwpadl0 bwtopsingle bwleftsingle bwrightsingle" rowspan="1"><p class="bwalignc bwcellpmargin"> <b>Number of Voting Rights (1) (2)</b> </p> </td> </tr> <tr> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Theoretical Voting Rights</i></b> </p> </td> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwrightsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Exercisable Voting Rights</i></b> </p> </td> </tr> <tr> <td class="bwsinglebottom bwleftsingle http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html Thu, 27 Aug 2026 12:00:00 -0400 A.40419557 ABLD O.00384728 O.00384891 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html <p class="bwalignc"> <b>(Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)</b> </p> <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics: (Paris:ABLD) </p><table cellspacing="0" class="bwtablemarginb bwblockalignl bwwidth100"> <tr> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Date</b> </p> </td> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Total Number of Shares Constituting the Share Capital</b> </p> </td> <td colspan="2" class="bwrowaltcolor0 bwpadl0 bwtopsingle bwleftsingle bwrightsingle" rowspan="1"><p class="bwalignc bwcellpmargin"> <b>Number of Voting Rights (1) (2)</b> </p> </td> </tr> <tr> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Theoretical Voting Rights</i></b> </p> </td> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwrightsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Exercisable Voting Rights</i></b> </p> </td> </tr> <tr> <td class="bwsinglebottom bwleftsingle http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html Thu, 27 Aug 2026 12:00:00 -0400 A.40419557 ABLD O.00384728 O.00384891 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html <p class="bwalignc"> <b>(Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)</b> </p> <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics: (Paris:ABLD) </p><table cellspacing="0" class="bwtablemarginb bwblockalignl bwwidth100"> <tr> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Date</b> </p> </td> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Total Number of Shares Constituting the Share Capital</b> </p> </td> <td colspan="2" class="bwrowaltcolor0 bwpadl0 bwtopsingle bwleftsingle bwrightsingle" rowspan="1"><p class="bwalignc bwcellpmargin"> <b>Number of Voting Rights (1) (2)</b> </p> </td> </tr> <tr> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Theoretical Voting Rights</i></b> </p> </td> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwrightsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Exercisable Voting Rights</i></b> </p> </td> </tr> <tr> <td class="bwsinglebottom bwleftsingle http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html Thu, 27 Aug 2026 12:00:00 -0400 A.40419557 ABLD O.00384728 O.00384891 http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html <p class="bwalignc"> <b>(Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)</b> </p> <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics: (Paris:ABLD) </p><table cellspacing="0" class="bwtablemarginb bwblockalignl bwwidth100"> <tr> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Date</b> </p> </td> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Total Number of Shares Constituting the Share Capital</b> </p> </td> <td colspan="2" class="bwrowaltcolor0 bwpadl0 bwtopsingle bwleftsingle bwrightsingle" rowspan="1"><p class="bwalignc bwcellpmargin"> <b>Number of Voting Rights (1) (2)</b> </p> </td> </tr> <tr> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Theoretical Voting Rights</i></b> </p> </td> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwrightsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Exercisable Voting Rights</i></b> </p> </td> </tr> <tr> <td class="bwsinglebottom bwleftsingle http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html Thu, 27 Aug 2026 12:00:00 -0400 A.40419557 ABLD O.00384728 O.00384891 http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html <p class="bwalignc"> <b>(Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)</b> </p> <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics: (Paris:ABLD) </p><table cellspacing="0" class="bwtablemarginb bwblockalignl bwwidth100"> <tr> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Date</b> </p> </td> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Total Number of Shares Constituting the Share Capital</b> </p> </td> <td colspan="2" class="bwrowaltcolor0 bwpadl0 bwtopsingle bwleftsingle bwrightsingle" rowspan="1"><p class="bwalignc bwcellpmargin"> <b>Number of Voting Rights (1) (2)</b> </p> </td> </tr> <tr> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Theoretical Voting Rights</i></b> </p> </td> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwrightsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Exercisable Voting Rights</i></b> </p> </td> </tr> <tr> <td class="bwsinglebottom bwleftsingle http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html Thu, 27 Aug 2026 12:00:00 -0400 A.40419557 ABLD O.00384728 O.00384891 http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html <p class="bwalignc"> <b>(Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)</b> </p> <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics: (Paris:ABLD) </p><table cellspacing="0" class="bwtablemarginb bwblockalignl bwwidth100"> <tr> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Date</b> </p> </td> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Total Number of Shares Constituting the Share Capital</b> </p> </td> <td colspan="2" class="bwrowaltcolor0 bwpadl0 bwtopsingle bwleftsingle bwrightsingle" rowspan="1"><p class="bwalignc bwcellpmargin"> <b>Number of Voting Rights (1) (2)</b> </p> </td> </tr> <tr> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Theoretical Voting Rights</i></b> </p> </td> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwrightsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Exercisable Voting Rights</i></b> </p> </td> </tr> <tr> <td class="bwsinglebottom bwleftsingle http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html Thu, 27 Aug 2026 12:00:00 -0400 A.40419557 ABLD O.00384728 O.00384891 http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html <p class="bwalignc"> <b>(Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)</b> </p> <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics: (Paris:ABLD) </p><table cellspacing="0" class="bwtablemarginb bwblockalignl bwwidth100"> <tr> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Date</b> </p> </td> <td rowspan="2" class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwvertalignm" colspan="1"><p class="bwalignc bwcellpmargin"> <b>Total Number of Shares Constituting the Share Capital</b> </p> </td> <td colspan="2" class="bwrowaltcolor0 bwpadl0 bwtopsingle bwleftsingle bwrightsingle" rowspan="1"><p class="bwalignc bwcellpmargin"> <b>Number of Voting Rights (1) (2)</b> </p> </td> </tr> <tr> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Theoretical Voting Rights</i></b> </p> </td> <td class="bwrowaltcolor0 bwpadl0 bwsinglebottom bwwidth25 bwtopsingle bwleftsingle bwrightsingle" rowspan="1" colspan="1"><p class="bwalignc bwcellpmargin"> <b><i>Exercisable Voting Rights</i></b> </p> </td> </tr> <tr> <td class="bwsinglebottom bwleftsingle http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Information+Relating+to+the+Total+Number+of+Voting+Rights+and+the+Number+of+Shares+Constituting+the+Share+Capital/26987828.html Thu, 27 Aug 2026 12:00:00 -0400 A.40419557 ABLD O.00384728 O.00384891 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Press+Releases/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend an Ordinary and Extraordinary General Meeting to be held on Thursday, September 17, 2026, at 11:00 a.m., at the offices of the law firm De Gaulle Fleurance &amp; Associés, located at 9 rue Boissy d'Anglas, 75008 Paris, France. </p><p> This General Meeting is being held to consider and vote on the proposed transfer of the listing of the Company's shares from the regulated market of Euronext Paris to the multilateral trading facility Euronext Growth Paris, as well as on the proposed change of http://www.streetinsider.com/Business+Wire/ABL+Diagnostics%3A+Ordinary+and+Extraordinary+General+Meeting+of+September+17%2C+2026+%E2%80%93+Arrangements+for+the+Availability+and+Consultation+of+Preparatory+Documents/26987829.html Thu, 27 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics+-+Proposed+Transfer+of+the+Listing+of+Its+Securities+From+the+Regulated+Market+of+Euronext+Paris+to+Euronext+Growth+Paris/26889621.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the "Company"), an international company specializing in innovative molecular biology tests and global solutions for laboratories, announces that its Board of Directors, meeting on August 6, 2026, has decided to convene a shareholders' meeting on September 17, 2026, for the purpose of submitting for their approval the proposed transfer of the listing of the Company's securities from the regulated market of Euronext Paris to the Euronext Growth Paris multilateral trading facility. </p><p> <b>Rationale for the proposed transfer</b> </p><p> This proposed transfer would allow the Company to be listed on http://www.streetinsider.com/Press+Releases/ABL+Diagnostics+-+Proposed+Transfer+of+the+Listing+of+Its+Securities+From+the+Regulated+Market+of+Euronext+Paris+to+Euronext+Growth+Paris/26889621.html Fri, 07 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics+-+Proposed+Transfer+of+the+Listing+of+Its+Securities+From+the+Regulated+Market+of+Euronext+Paris+to+Euronext+Growth+Paris/26889621.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the "Company"), an international company specializing in innovative molecular biology tests and global solutions for laboratories, announces that its Board of Directors, meeting on August 6, 2026, has decided to convene a shareholders' meeting on September 17, 2026, for the purpose of submitting for their approval the proposed transfer of the listing of the Company's securities from the regulated market of Euronext Paris to the Euronext Growth Paris multilateral trading facility. </p><p> <b>Rationale for the proposed transfer</b> </p><p> This proposed transfer would allow the Company to be listed on http://www.streetinsider.com/Press+Releases/ABL+Diagnostics+-+Proposed+Transfer+of+the+Listing+of+Its+Securities+From+the+Regulated+Market+of+Euronext+Paris+to+Euronext+Growth+Paris/26889621.html Fri, 07 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics+-+Proposed+Transfer+of+the+Listing+of+Its+Securities+From+the+Regulated+Market+of+Euronext+Paris+to+Euronext+Growth+Paris/26889621.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the "Company"), an international company specializing in innovative molecular biology tests and global solutions for laboratories, announces that its Board of Directors, meeting on August 6, 2026, has decided to convene a shareholders' meeting on September 17, 2026, for the purpose of submitting for their approval the proposed transfer of the listing of the Company's securities from the regulated market of Euronext Paris to the Euronext Growth Paris multilateral trading facility. </p><p> <b>Rationale for the proposed transfer</b> </p><p> This proposed transfer would allow the Company to be listed on http://www.streetinsider.com/Press+Releases/ABL+Diagnostics+-+Proposed+Transfer+of+the+Listing+of+Its+Securities+From+the+Regulated+Market+of+Euronext+Paris+to+Euronext+Growth+Paris/26889621.html Fri, 07 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics+-+Proposed+Transfer+of+the+Listing+of+Its+Securities+From+the+Regulated+Market+of+Euronext+Paris+to+Euronext+Growth+Paris/26889621.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the "Company"), an international company specializing in innovative molecular biology tests and global solutions for laboratories, announces that its Board of Directors, meeting on August 6, 2026, has decided to convene a shareholders' meeting on September 17, 2026, for the purpose of submitting for their approval the proposed transfer of the listing of the Company's securities from the regulated market of Euronext Paris to the Euronext Growth Paris multilateral trading facility. </p><p> <b>Rationale for the proposed transfer</b> </p><p> This proposed transfer would allow the Company to be listed on http://www.streetinsider.com/Press+Releases/ABL+Diagnostics+-+Proposed+Transfer+of+the+Listing+of+Its+Securities+From+the+Regulated+Market+of+Euronext+Paris+to+Euronext+Growth+Paris/26889621.html Fri, 07 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722 http://www.streetinsider.com/Press+Releases/ABL+Diagnostics+-+Proposed+Transfer+of+the+Listing+of+Its+Securities+From+the+Regulated+Market+of+Euronext+Paris+to+Euronext+Growth+Paris/26889621.html <p> WOIPPY, France--(BUSINESS WIRE)-- Regulatory News: </p><p> ABL Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the "Company"), an international company specializing in innovative molecular biology tests and global solutions for laboratories, announces that its Board of Directors, meeting on August 6, 2026, has decided to convene a shareholders' meeting on September 17, 2026, for the purpose of submitting for their approval the proposed transfer of the listing of the Company's securities from the regulated market of Euronext Paris to the Euronext Growth Paris multilateral trading facility. </p><p> <b>Rationale for the proposed transfer</b> </p><p> This proposed transfer would allow the Company to be listed on http://www.streetinsider.com/Press+Releases/ABL+Diagnostics+-+Proposed+Transfer+of+the+Listing+of+Its+Securities+From+the+Regulated+Market+of+Euronext+Paris+to+Euronext+Growth+Paris/26889621.html Fri, 07 Aug 2026 12:00:00 -0400 A.26800952 A.40419557 ABLD O.00384728 O.00384891 O.00711722